Silencing Met receptor tyrosine kinase signaling decreased oral tumor growth and increased survival of nude mice

X. Tao, K. S. Hill, I. Gaziova, S. K. Sastry, S. Qui, P. Szaniszlo, S. Fennewald, Vicente Resto, Lisa Elferink

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objectives: The hepatocyte growth factor receptor (Met) is frequently overexpressed in Head and Neck Squamous Cell Carcinoma (HNSCC), correlating positively with high-grade tumors and shortened patient survival. As such, Met may represent an important therapeutic target. The purpose of this study was to explore the role of Met signaling for HNSCC growth and locoregional dissemination. Materials and methods: Using a lentiviral system for RNA interference, we knocked down Met in established HNSCC cell lines that express high levels of the endogenous receptor. The effect of Met silencing on in vitro proliferation, cell survival and migration was examined using western analysis, immunohistochemistry and live cell imaging. In vivo tumor growth, dissemination and mouse survival was assessed using an orthotopic tongue mouse model for HNSCC. Results: We show that Met knockdown (1) impaired activation of downstream MAPK signaling; (2) reduced cell viability and anchorage independent growth; (3) abrogated HGF-induced cell motility on laminin; (4) reduced in vivo tumor growth by increased cell apoptosis; (5) caused reduced incidence of tumor dissemination to regional lymph nodes and (6) increased the survival of nude mice with orthotopic xenografts. Conclusion: Met signaling is important for HNSCC growth and locoregional dissemination in vivo and that targeting Met may be an important strategy for therapy.

Original languageEnglish (US)
Pages (from-to)104-112
Number of pages9
JournalOral Oncology
Volume50
Issue number2
DOIs
StatePublished - Feb 2014

Fingerprint

Receptor Protein-Tyrosine Kinases
Nude Mice
Growth
Neoplasms
Cell Movement
Cell Survival
Proto-Oncogene Proteins c-met
Laminin
RNA Interference
Tongue
Heterografts
Lymph Nodes
Immunohistochemistry
Carcinoma, squamous cell of head and neck
Apoptosis
Cell Line
Survival
Incidence
Therapeutics

Keywords

  • Head and neck squamous cell carcinoma
  • HGF receptor
  • MET
  • Oral cancer
  • Tumorigenesis

ASJC Scopus subject areas

  • Oncology
  • Oral Surgery
  • Cancer Research

Cite this

Silencing Met receptor tyrosine kinase signaling decreased oral tumor growth and increased survival of nude mice. / Tao, X.; Hill, K. S.; Gaziova, I.; Sastry, S. K.; Qui, S.; Szaniszlo, P.; Fennewald, S.; Resto, Vicente; Elferink, Lisa.

In: Oral Oncology, Vol. 50, No. 2, 02.2014, p. 104-112.

Research output: Contribution to journalArticle

Tao, X. ; Hill, K. S. ; Gaziova, I. ; Sastry, S. K. ; Qui, S. ; Szaniszlo, P. ; Fennewald, S. ; Resto, Vicente ; Elferink, Lisa. / Silencing Met receptor tyrosine kinase signaling decreased oral tumor growth and increased survival of nude mice. In: Oral Oncology. 2014 ; Vol. 50, No. 2. pp. 104-112.
@article{58cb895bf0c04ded8186fc3cacda0eb3,
title = "Silencing Met receptor tyrosine kinase signaling decreased oral tumor growth and increased survival of nude mice",
abstract = "Objectives: The hepatocyte growth factor receptor (Met) is frequently overexpressed in Head and Neck Squamous Cell Carcinoma (HNSCC), correlating positively with high-grade tumors and shortened patient survival. As such, Met may represent an important therapeutic target. The purpose of this study was to explore the role of Met signaling for HNSCC growth and locoregional dissemination. Materials and methods: Using a lentiviral system for RNA interference, we knocked down Met in established HNSCC cell lines that express high levels of the endogenous receptor. The effect of Met silencing on in vitro proliferation, cell survival and migration was examined using western analysis, immunohistochemistry and live cell imaging. In vivo tumor growth, dissemination and mouse survival was assessed using an orthotopic tongue mouse model for HNSCC. Results: We show that Met knockdown (1) impaired activation of downstream MAPK signaling; (2) reduced cell viability and anchorage independent growth; (3) abrogated HGF-induced cell motility on laminin; (4) reduced in vivo tumor growth by increased cell apoptosis; (5) caused reduced incidence of tumor dissemination to regional lymph nodes and (6) increased the survival of nude mice with orthotopic xenografts. Conclusion: Met signaling is important for HNSCC growth and locoregional dissemination in vivo and that targeting Met may be an important strategy for therapy.",
keywords = "Head and neck squamous cell carcinoma, HGF receptor, MET, Oral cancer, Tumorigenesis",
author = "X. Tao and Hill, {K. S.} and I. Gaziova and Sastry, {S. K.} and S. Qui and P. Szaniszlo and S. Fennewald and Vicente Resto and Lisa Elferink",
year = "2014",
month = "2",
doi = "10.1016/j.oraloncology.2013.10.014",
language = "English (US)",
volume = "50",
pages = "104--112",
journal = "Oral Oncology",
issn = "1368-8375",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Silencing Met receptor tyrosine kinase signaling decreased oral tumor growth and increased survival of nude mice

AU - Tao, X.

AU - Hill, K. S.

AU - Gaziova, I.

AU - Sastry, S. K.

AU - Qui, S.

AU - Szaniszlo, P.

AU - Fennewald, S.

AU - Resto, Vicente

AU - Elferink, Lisa

PY - 2014/2

Y1 - 2014/2

N2 - Objectives: The hepatocyte growth factor receptor (Met) is frequently overexpressed in Head and Neck Squamous Cell Carcinoma (HNSCC), correlating positively with high-grade tumors and shortened patient survival. As such, Met may represent an important therapeutic target. The purpose of this study was to explore the role of Met signaling for HNSCC growth and locoregional dissemination. Materials and methods: Using a lentiviral system for RNA interference, we knocked down Met in established HNSCC cell lines that express high levels of the endogenous receptor. The effect of Met silencing on in vitro proliferation, cell survival and migration was examined using western analysis, immunohistochemistry and live cell imaging. In vivo tumor growth, dissemination and mouse survival was assessed using an orthotopic tongue mouse model for HNSCC. Results: We show that Met knockdown (1) impaired activation of downstream MAPK signaling; (2) reduced cell viability and anchorage independent growth; (3) abrogated HGF-induced cell motility on laminin; (4) reduced in vivo tumor growth by increased cell apoptosis; (5) caused reduced incidence of tumor dissemination to regional lymph nodes and (6) increased the survival of nude mice with orthotopic xenografts. Conclusion: Met signaling is important for HNSCC growth and locoregional dissemination in vivo and that targeting Met may be an important strategy for therapy.

AB - Objectives: The hepatocyte growth factor receptor (Met) is frequently overexpressed in Head and Neck Squamous Cell Carcinoma (HNSCC), correlating positively with high-grade tumors and shortened patient survival. As such, Met may represent an important therapeutic target. The purpose of this study was to explore the role of Met signaling for HNSCC growth and locoregional dissemination. Materials and methods: Using a lentiviral system for RNA interference, we knocked down Met in established HNSCC cell lines that express high levels of the endogenous receptor. The effect of Met silencing on in vitro proliferation, cell survival and migration was examined using western analysis, immunohistochemistry and live cell imaging. In vivo tumor growth, dissemination and mouse survival was assessed using an orthotopic tongue mouse model for HNSCC. Results: We show that Met knockdown (1) impaired activation of downstream MAPK signaling; (2) reduced cell viability and anchorage independent growth; (3) abrogated HGF-induced cell motility on laminin; (4) reduced in vivo tumor growth by increased cell apoptosis; (5) caused reduced incidence of tumor dissemination to regional lymph nodes and (6) increased the survival of nude mice with orthotopic xenografts. Conclusion: Met signaling is important for HNSCC growth and locoregional dissemination in vivo and that targeting Met may be an important strategy for therapy.

KW - Head and neck squamous cell carcinoma

KW - HGF receptor

KW - MET

KW - Oral cancer

KW - Tumorigenesis

UR - http://www.scopus.com/inward/record.url?scp=84891833437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891833437&partnerID=8YFLogxK

U2 - 10.1016/j.oraloncology.2013.10.014

DO - 10.1016/j.oraloncology.2013.10.014

M3 - Article

VL - 50

SP - 104

EP - 112

JO - Oral Oncology

JF - Oral Oncology

SN - 1368-8375

IS - 2

ER -